272 related articles for article (PubMed ID: 25868978)
1. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
Deshmukh SK; Srivastava SK; Bhardwaj A; Singh AP; Tyagi N; Marimuthu S; Dyess DL; Dal Zotto V; Carter JE; Singh S
Oncotarget; 2015 May; 6(13):11231-41. PubMed ID: 25868978
[TBL] [Abstract][Full Text] [Related]
2. Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.
Deshmukh SK; Srivastava SK; Zubair H; Bhardwaj A; Tyagi N; Al-Ghadhban A; Singh AP; Dyess DL; Carter JE; Singh S
Cancer Lett; 2017 Jun; 396():21-29. PubMed ID: 28302531
[TBL] [Abstract][Full Text] [Related]
3. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Vallega KA; Liu N; Myers JS; Yu K; Sang QX
PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine levels and breast cancer risk factors: racial differences of healthy Caucasian and African American women.
Park NJ; Kang DH
Oncol Nurs Forum; 2013 Sep; 40(5):490-500. PubMed ID: 23975184
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
Kalla Singh S; Tan QW; Brito C; De León M; De León D
Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
[TBL] [Abstract][Full Text] [Related]
6. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
7. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
Grunda JM; Steg AD; He Q; Steciuk MR; Byan-Parker S; Johnson MR; Grizzle WE
BMC Res Notes; 2012 May; 5():248. PubMed ID: 22616718
[TBL] [Abstract][Full Text] [Related]
9. Targeting risk factors for reducing the racially disparate burden in breast cancer.
Wright N; Akinyemiju T; Subhedar P; Rida P; Aneja R
Front Biosci (Schol Ed); 2019 Mar; 11(1):136-160. PubMed ID: 30844741
[TBL] [Abstract][Full Text] [Related]
10. Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression.
Li G; Zhao L; Li W; Fan K; Qian W; Hou S; Wang H; Dai J; Wei H; Guo Y
Oncotarget; 2014 Sep; 5(18):8317-29. PubMed ID: 25327561
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
13. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
[TBL] [Abstract][Full Text] [Related]
14. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
16. STAT3 can be activated through paracrine signaling in breast epithelial cells.
Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
[TBL] [Abstract][Full Text] [Related]
17. IL-6 and Soluble Receptors in Overweight and Obese African American Women With and Without Breast Cancer.
Griffith KA; Ryan AS
Biol Res Nurs; 2021 Apr; 23(2):218-222. PubMed ID: 32748635
[TBL] [Abstract][Full Text] [Related]
18. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
[TBL] [Abstract][Full Text] [Related]
19. SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.
Xing J; Li J; Fu L; Gai J; Guan J; Li Q
Cancer Med; 2019 Nov; 8(16):7086-7097. PubMed ID: 31573734
[TBL] [Abstract][Full Text] [Related]
20. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
